How do I find out if I qualify for a recurrent lung non-small cell carcinoma study in Pennsylvania?

Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.

Do I have to live in Pennsylvania to take part?

Not necessarily. These studies have a site in Pennsylvania, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.

Does it cost anything to join a recurrent lung non-small cell carcinoma trial?

Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.

Clinical trials · Pennsylvania

Recurrent Lung Non-Small Cell Carcinoma clinical trials in Pennsylvania

We’re tracking 28 recruiting recurrent lung non-small cell carcinoma studies with a site in Pennsylvania — including Phase 1, Phase 2 and Phase 3 studies, each written for real people, not researchers.

Recruiting studies in Pennsylvania

NCT04429542RecruitingPhase 1
Test of an EGFR-targeting drug for advanced solid cancers
This Phase 1 study tests the safety of BCA101 (an EGFR-targeting treatment) alone or combined with pembrolizumab. It may help people with certain EGFR-driven advanced cancers, depending on the tumor type, prior treatments, and required biopsy testing.
Pittsburgh, PennsylvaniaAges 18 years+
NCT04181060RecruitingPhase 3
Osimertinib alone or with bevacizumab for EGFR-mutant lung cancer
This Phase 3 trial tests whether starting osimertinib with or without bevacizumab helps people with advanced EGFR-mutant lung cancer live longer and control the cancer better. Your EGFR mutation test result and past treatments are key to whether you can join.
Allentown, PennsylvaniaAges 18 years+
NCT03808337RecruitingPhase 2
SBRT radiation plus standard treatment for spread cancer
This trial looks at adding a focused radiation treatment called SBRT to standard care for cancers that have spread to a limited number of spots. It aims to control those spread-out tumors while still using the usual cancer treatment plan.
Allentown, PennsylvaniaAges 18 years+
NCT03191149RecruitingPhase 2
Osimertinib for lung cancer with an EGFR exon 20 change
This Phase 2 study tests osimertinib (a targeted lung cancer pill) in people with advanced non-small cell lung cancer (NSCLC) whose tumors have an EGFR exon 20 insertion. It aims to see how well osimertinib works for this specific EGFR mutation and how safe it is.
Allentown, PennsylvaniaAges 18 years+

Recurrent Lung Non-Small Cell Carcinoma trials by city in Pennsylvania

Where these studies are running in Pennsylvania

Institutions with a site for the recruiting recurrent lung non-small cell carcinoma studies listed above.

Lehigh Valley Hospital-Cedar Crest · 3 studies
Bryn Mawr Hospital · 2 studies
Fox Chase Cancer Center · 2 studies
Lankenau Medical Center · 2 studies
Lehigh Valley Hospital - Muhlenberg · 2 studies
Lehigh Valley Hospital-Hazleton · 2 studies
Main Line Health Center-Collegeville · 2 studies
Main Line Health Center-Exton · 2 studies

What taking part in a recurrent lung non-small cell carcinoma study involves

A screening visit first

Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.

Care at a nearby site

Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.

You stay in control

Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.

The team decides eligibility

Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.

Recurrent Lung Non-Small Cell Carcinoma trials in other states

Common questions

Are there recurrent lung non-small cell carcinoma clinical trials in Pennsylvania?: Yes. We're currently tracking 28 recruiting recurrent lung non-small cell carcinoma studies with a site in Pennsylvania, each rewritten in plain language so you can see what it's testing and who it's for.
How do I find out if I qualify for a recurrent lung non-small cell carcinoma study in Pennsylvania?: Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
Do I have to live in Pennsylvania to take part?: Not necessarily. These studies have a site in Pennsylvania, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
Does it cost anything to join a recurrent lung non-small cell carcinoma trial?: Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.

Not the right time?

New recurrent lung non-small cell carcinoma studies open in Pennsylvania regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.

Get told when a study that fits you opens

Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.